Solubility and Dissolution Enhancement of Dexibuprofen by Inclusion Complexation with Cyclodextrin

被引:0
作者
Munir, Rabia [1 ]
Mashood, Usama [2 ]
Asghar, Sajid [1 ]
Khan, Ikram Ullah [1 ]
Irfan, Muhammad [1 ]
Inam, Sana [1 ]
Islam, Nayyer [1 ,3 ]
Ajaz, Nyla [1 ,4 ]
Hassan, Shahzadi Filza [1 ]
Anwar, Saniya [1 ]
Shah, Pervaiz A. [5 ]
Saleem, Muhammad [5 ]
Iqbal, Muhammad Shahid [6 ]
Syed, Haroon Khalid [1 ]
机构
[1] Govt Coll Univ, Fac Pharmaceut Sci, Dept Pharmaceut, Faisalabad 38000, Pakistan
[2] Xian Jiaotong Univ China, Dept Med, Xian 710000, Shaanxi, Peoples R China
[3] Univ Lahore, Dept Pharm, Lahore, Pakistan
[4] Univ Faisalabad, Dept Pharm, Faisalabad 38000, Pakistan
[5] Univ Punjab, Univ Coll Pharm, Lahore 54590, Pakistan
[6] Prince Sattam Bin Abdulaziz Univ, Coll Pharm, Dept Clin Pharm, Al Kharj 11942, Saudi Arabia
来源
LATIN AMERICAN JOURNAL OF PHARMACY | 2022年 / 41卷 / 01期
关键词
Dexibuprofen; solubility; Cyclodextrin; binary inclusion complexes; in vitro release; BETA-CYCLODEXTRIN;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The solubility enhancement ability of different methods was compared by using dexibuprofen (DEX) as a model drug. Binary inclusion complexes of DEX were prepared with beta cyclodextrin (beta CD) at weight ratio of 1:1,1:2 and 1:4 by physical trituration (PT), kneading (KN) and solvent evaporation (SE) method. The phase solubility studies illustrated that DEX solubility increased proportionally with an increase in beta CD concentration. The solubility of DEX was significantly higher when complexed with beta CD by KN method. DEX-beta CD complexes were examined critically by using infrared (FTIR), differential scanning calorimetry (DSC), powder X-ray diffraction (XRD) and scanning electron microscopy (SEM). FTIR and XRD did not show any significant difference between DEX-beta CD complexes prepared by PT and KN method. DSC thermograms of DEX-beta CD prepared by KN method were showed a decrease in the intensity of endothermic peak of DEX more than PT method. XRD results indicated that DEX shifted to less crystalline state when complexed with beta CD. In conclusion, beta CD is suitable to increase the solubility of DEX.
引用
收藏
页码:235 / 243
页数:9
相关论文
共 26 条
[1]   A THEORETICAL BASIS FOR A BIOPHARMACEUTIC DRUG CLASSIFICATION - THE CORRELATION OF IN-VITRO DRUG PRODUCT DISSOLUTION AND IN-VIVO BIOAVAILABILITY [J].
AMIDON, GL ;
LENNERNAS, H ;
SHAH, VP ;
CRISON, JR .
PHARMACEUTICAL RESEARCH, 1995, 12 (03) :413-420
[2]   Effect of Hydrophilic Polymers on Complexation Efficiency of Cyclodextrins in Enhancing Solubility and Release of Diflunisal [J].
Bashir, Mehreen ;
Syed, Haroon Khalid ;
Asghar, Sajid ;
Irfan, Muhammad ;
Almalki, Waleed Hassan ;
Menshawi, Salah Ali ;
Khan, Ikram Ullah ;
Shah, Pervaiz A. ;
Khalid, Ikrima ;
Ahmad, Junaid ;
Gohar, Umar Farooq ;
Peh, Kok Khiang ;
Iqbal, Muhammad Shahid .
POLYMERS, 2020, 12 (07)
[3]  
Boushra M. El-H., 2014, DRUG DISCOV THER, V8, P178
[4]   Cyclodextrins as pharmaccutical solubilizers [J].
Brewster, Marcus E. ;
Loftsson, Thorsteinn .
ADVANCED DRUG DELIVERY REVIEWS, 2007, 59 (07) :645-666
[5]   PHARMACEUTICAL APPLICATIONS OF SOLID DISPERSION SYSTEMS [J].
CHIOU, WL ;
RIEGELMAN, S .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1971, 60 (09) :1281-+
[6]   Cyclodextrin Mediated Controlled Release of Naproxen from pH-Sensitive Chitosan/Poly(Vinyl Alcohol) Hydrogels for Colon Targeted Delivery [J].
Das, Subhraseema ;
Subuddhi, Usharani .
INDUSTRIAL & ENGINEERING CHEMISTRY RESEARCH, 2013, 52 (39) :14192-14200
[7]  
Dua Kamal, 2007, Current Drug Delivery, V4, P21, DOI 10.2174/156720107779314776
[8]   Infective exacerbations of chronic bronchitis - Relation between bacteriologic etiology and lung function [J].
Eller, J ;
Ede, A ;
Schaberg, T ;
Niederman, MS ;
Mauch, H ;
Lode, H .
CHEST, 1998, 113 (06) :1542-1548
[9]   Influence of soluble and insoluble cyclodextrin polymers on drug release from hydroxypropyl methylcellulose tablets [J].
Esther Zugasti, Maria ;
Zornoza, Arantza ;
del Mar Goni, Maria ;
Ramon Isasi, Jose ;
Velaz, Itziar ;
Martin, Carmen ;
Sanchez, Miguel ;
Cristina Martinez-Oharriz, Maria .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2009, 35 (10) :1264-1270
[10]   Comparative pharmacology of s(+)-ibuprofen and (RS)-ibuprofen [J].
Evans, AM .
CLINICAL RHEUMATOLOGY, 2001, 20 (Suppl 1) :9-14